GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaEssentia Corp (TPE:6446) » Definitions » Debt-to-Revenue

PharmaEssentia (TPE:6446) Debt-to-Revenue : 0.12 (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PharmaEssentia Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PharmaEssentia's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$215 Mil. PharmaEssentia's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$861 Mil. PharmaEssentia's annualized Revenue for the quarter that ended in Jun. 2024 was NT$9,226 Mil. PharmaEssentia's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.12.


PharmaEssentia Debt-to-Revenue Historical Data

The historical data trend for PharmaEssentia's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEssentia Debt-to-Revenue Chart

PharmaEssentia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 1.16 0.82 0.54 0.24

PharmaEssentia Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.18 0.17 0.12

Competitive Comparison of PharmaEssentia's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Debt-to-Revenue falls into.



PharmaEssentia Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PharmaEssentia's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(245.224 + 954.998) / 5105.615
=0.24

PharmaEssentia's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(215.286 + 861.303) / 9225.932
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2024) Revenue data.


PharmaEssentia Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PharmaEssentia's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaEssentia Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 2nd Floor, No. 5, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp is engaged in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug pattern developments. It focuses on Hematology, Oncology, and Infectious Disease. The company derives its revenue from sales of medicine products.

PharmaEssentia Headlines

No Headlines